Numerous genome-wide associated studies suggest that polymorphisms in the 5p13.1 regulatory region near PTGER4 (encoding human EP4) are significantly associated with PTGER4 gene expression and the susceptibility to MS (De Jager et al., 2009; Matesanz et al., 2012). Here, PTGER4 is linked to myeloid sarcoma.